Persistence of Delays in Presentation and Treatment for Patients With Acute Myocardial Infarction: The GUSTO-I and GUSTO-III Experience

Size: px
Start display at page:

Download "Persistence of Delays in Presentation and Treatment for Patients With Acute Myocardial Infarction: The GUSTO-I and GUSTO-III Experience"

Transcription

1 ORIGINAL CONTRIBUTION Persistence of Delays in Presentation and Treatment for Patients With Acute Myocardial Infarction: The GUSTO-I and GUSTO-III Experience From the Department of Emergency Medicine, University of Cincinnati, Cincinnati OH ; the Department of Medicine, University of Alberta, Edmonton, Alberta, Canada ; Duke Clinical Research Institute, Durham, NC ; Heart and Vascular Institute, Henry Ford Health System, Detroit, MI ll ; the Department of Medicine, University of Massachusetts Medical Center, Worcester, MA ; and the Cleveland Clinic Foundation, Cleveland, OH. # Author contributions are provided at the end of this article. Received for publication June 12, Revision received August 28, Accepted for publication October 30, Address for reprints: W. Brian Gibler, MD, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH ; , fax ; brian.gibler@uc.edu. Copyright 2002 by the American College of Emergency Physicians /2002/$ /1/ doi: /mem W. Brian Gibler, MD Paul W. Armstrong, MD E. Magnus Ohman, MD W. Douglas Weaver, MD ll Amanda L. Stebbins, MS Joel M. Gore, MD L. Kristin Newby, MD Robert M. Califf, MD Eric J. Topol, MD # For the Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) Investigators See editorial, p Study objective: Early treatment with fibrinolytic therapy substantially decreases mortality in acute myocardial infarction (AMI). We examined delays to hospital arrival and treatment in 2 large, multinational, randomized trials of fibrinolytic therapy: Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) and Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO- III). Methods: We evaluated delays to hospital arrival, time from arrival to treatment, and total time to treatment in the 27,849 US patients with AMI enrolled in GUSTO-I or GUSTO-III. Time intervals were defined prospectively for total time to treatment and symptom onset to hospital arrival as 0 to 2 hours (early), 2 to 4 hours, or more than 4 hours (late). Time to fibrinolytic therapy once inhospital was prospectively defined as 0 to 1 hour (early) or more than 1 hour (late). Socioeconomic data were also obtained from patients enrolled in the GUSTO-III trial. Results: In GUSTO-III, as in GUSTO-I, patients who arrived at the hospital later were older (64 years versus 60 years; P=.001) and more often female (35% versus 27%; P=.001), black (6% versus 4%; P=.02), and diabetic (25% versus 16%; P=.001). These groups also received treatment later once inhospital, as did patients with hypertension (48% versus 42%; P=.001), previous angina (46% versus 36%; P=.001), and previous infarction (21% versus 16%; P=.001). Higher levels of education, professional occupations, and private health insurance were associated with significantly earlier arrival and treatment. Although inhospital time to treatment has decreased (66 minutes to 48 minutes; P<.0001), time to arrival has not changed over the past 7 years, averaging 84 minutes. Conclusion: Certain groups of patients with AMI, including the elderly, women, diabetic patients, and minorities, exhibit delays to hospital arrival and treatment in the emergency set- FEBRUARY :2 ANNALS OF EMERGENCY MEDICINE 123

2 ting. Patients with higher educational levels, professional occupations, and private health insurance arrive at the hospital sooner and receive treatment more quickly. Patients and health care providers must be educated regarding high-risk populations for delay to maximize benefit from fibrinolytic therapy. [Gibler WB, Armstrong PW, Ohman EM, Weaver WD, Stebbins AL, Gore JM, Newby LK, Califf RM, Topol EJ, for the Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) Investigators. Persistence of delays in presentation and treatment for patients with acute myocardial infarction: the GUSTO-I and GUSTO-III experience. Ann Emerg Med. February 2002;39: ] INTRODUCTION A delay in receiving thrombolytic therapy for acute myocardial infarction (AMI) is associated with diminished treatment effect and increased mortality. 1 Although treatment administered up to 12 hours after symptom onset has proved beneficial, maximum benefit is achieved when therapy is provided within the first few hours. 2 Over the past decade, substantial public health efforts have successfully educated health care providers about the importance of timely treatment with thrombolytic therapy. 3 As a result, the time required to identify and treat patients with myocardial infarction in the emergency setting has been nearly halved. 4 Despite such success in decreasing time to treatment in the emergency department, no similar reduction in time from symptom onset to patient arrival at the hospital has been observed. In a study of all 41,021 patients enrolled in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) trial, certain patient groups arrived to the hospital late in the course of their AMI. 5 Female, elderly, diabetic, and hypertensive patients were found to be susceptible to delays in hospital arrival and treatment in the ED. We hypothesized that improvement in the inhospital time to treatment for US patients with AMI would be associated with a similar decrease in the delay from symptom onset to patient arrival to the hospital. Given the publication of national guidelines on time to thrombolytic treatment and rigorous public education initiatives since 1990, the Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO-III) trial, completed in February 1997, afforded us a unique opportunity to examine this hypothesis. The parallel designs of these 2 studies also allowed us to study 2 large and very similar patient groups separated by several years in which awareness and treatment of myocardial infarction were rapidly evolving. We sought to isolate the factors associated with both out-of-hospital and inhospital delays. Furthermore, through socioeconomic information obtained in the GUSTO-III trial, we examined the impact of educational level, occupation, health care insurance status, and living alone on time delays. MATERIALS AND METHODS Our analysis population consisted of the patients enrolled in the United States in the GUSTO-I and GUSTO-III trials. This study was approved by the institutional review boards of all participating clinical sites. GUSTO-I enrolled 41,021 patients in a multicenter, international trial evaluating 4 fibrinolytic regimens of streptokinase and tissue plasminogen activator. Complete methods for the GUSTO-I trial have been published. 6 In this trial, patients were randomized to 1 of 4 fibrinolytic regimens if they presented within 6 hours after symptom onset and had chest pain lasting 20 minutes or more. In addition, patients must have had no contraindications to thrombolysis and must have met electrocardiographic criteria for infarction (ST-segment elevation 0.1 mv in 2 limb leads or 0.2 mv in at least 2 contiguous precordial leads). The GUSTO-III trial enrolled 15,060 patients; complete methods have been published. 7 Inclusion criteria for patients in GUSTO-III were identical to GUSTO-I. This randomized, controlled clinical trial compared 2 different fibrinolytic regimens: alteplase versus reteplase. Electrocardiographic criteria for determining infarction were similar to those in GUSTO-I. Because practice patterns vary substantially between countries, our evaluation was limited to the 23,105 GUSTO-I patients and 4,744 GUSTO-III patients enrolled in the United States. In GUSTO-I and GUSTO-III, 3 time variables were defined prospectively: (1) time from symptom onset to hospital arrival (out-of-hospital delay), (2) time from hospital arrival to administration of thrombolytic therapy (inhospital delay), and (3) total time from symptom onset to treatment. The temporal frames of 0 to 2 hours, 2 to 4 hours, and more than 4 hours were based on a prespecified analysis in GUSTO-I for time to hospital arrival from symptom onset and total time to treatment. For GUSTO- III, time from arrival to treatment was prospectively divided into 2 groups reflecting early treatment (<1 hour) and late treatment (>1 hour). For these analyses, the time of symptom onset was provided by the patient, or a family member if the patient was unable to communicate. The time of patient arrival to 124 ANNALS OF EMERGENCY MEDICINE 39:2 FEBRUARY 2002

3 hospital was derived from hospital records, as was time of administration of fibrinolytic therapy. For the GUSTO-I and GUSTO-III trials, information on baseline characteristics including age, sex, race, height, and weight were prospectively collected. We prospectively defined the following baseline characteristics for our analysis of their association with time to hospital arrival: history of hypertension, diabetes, smoking, hypercholesterolemia, family history, history of angina, myocardial infarction, coronary artery bypass grafting, and angioplasty. Physical examination data, including pulse rate, systolic and diastolic blood pressure, presence of congestive heart failure, and anatomic location of the infarction were also gathered. In GUSTO-III only, socioeconomic data were prospectively obtained to identify the impact of education level, occupation, payer status, and living alone on time to hospital arrival and time to treatment. Descriptive statistics, including percentages for discrete variables and medians with 25th and 75th percentiles for continuous variables, were used for baseline characteristic determination and time to treatment data for GUSTO-I and GUSTO-III patients. Statistical testing was performed using the χ 2 test for categoric variables and Cox modeling for continuous variables. A P value less than.05 was considered significant. Because enrollment criteria and baseline data in GUSTO-I and GUSTO-III were identical, these databases were combined to maximize power for the analysis. No distributional assumptions were made for the dependent variables, time to hospital arrival, and time from hospital arrival to treatment. On the basis of the GUSTO-I analysis that identified the principal features associated with delay in presentation, we performed a univariate analysis that identified age, sex, race, and diabetes as independent predictors of delay in hospital arrival for patients. Similarly, the patient s age, sex, race, pulse rate, previous angina, previous infarction, previous bypass surgery, and infarct location were found to be predictive of delay in time to treatment after hospital arrival. We then used stepwise regression modeling to evaluate the influence of socioeconomic factors on delay obtained in GUSTO-III. The socioeconomic factors that were evaluated included years of education, occupation, type of insurance, and living alone. RESULTS The baseline characteristics of patients enrolled in GUSTO-III were similar to those of patients enrolled in GUSTO-I. Thirty-day mortality was also similar for the 2 groups (Table 1). The time from symptom onset to hospital arrival did not change during the 7-year period from the start of GUSTO-I in 1990 to the end of GUSTO-III in 1997 (Table 2). The time from arrival to treatment with fibrinolytic Table 1. GUSTO-I and GUSTO-III baseline characteristics and mortality. GUSTO-I GUSTO-III Characteristic (n=23,105) (n=4,744) Age, y 61.1 (51.5, 69.8) 61.5 (51.5, 71.2) Female sex 6,278 (27.2) 1,346 (29.7) Weight, kg 80.2 (70.1, 91) 81.8 (71, 93) Height, cm (165.1, 180) 172 (165, 179) Race Black 1,113 (4.8) 222 (4.9) Other 962 (4.2) 199 (4.4) White 20,962 (91.0) 4,108 (90.7) Hypertension 9,821 (42.7) 1,994 (44.0) Diabetes mellitus 3,820 (16.6) 819 (18.1) Hypercholesterolemia 8,473 (37.9) 1,873 (41.5) Previous myocardial infarction 3,943 (17.1) 809 (17.9) Systolic blood pressure, mm Hg 126 (110, 142) 133 (116, 150) Pulse rate, beats/min 74 (63, 86) 74 (62, 87) Killip class I 19,950 (87.1) 4,092 (91.4) II 2,507 (11.0) 334 (7.5) III 250 (1.1) 32 (0.71) IV 187 (0.82) 21 (0.47) Anterior infarction 8,591 (37.4) 1,994 (44.0) Inferior infarction 13,694 (59.6) 2,385 (52.6) Inhospital mortality 1,495 (6.5) 246 (5.4) Mortality by 30 d 1,562 (6.8) 286 (6.3) Results are expressed as numbers (percentages) or median (25th, 75th percentiles). Table 2. Comparison of the GUSTO-I trial to the GUSTO-III trial: Time from symptom onset to hospital arrival, hospital arrival to treatment, and time from symptom onset to treatment. GUSTO-I GUSTO-III P Interval Times (n=23,105) (n=4,744) Value Enrollment years Symptom onset to hospital arrival, h 1.4 (0.9, 2.3) 1.4 (0.8, 2.3).09 Hospital arrival to treatment, h 1.1 (0.8, 1.5) 0.8 (0.6, 1.2) <.0001 Total time to treatment, h 2.7 (1.9, 3.8) 2.3 (1.6, 3.3) <.0001 Data are median (25th, 75th percentiles). FEBRUARY :2 ANNALS OF EMERGENCY MEDICINE 125

4 therapy did decrease during this period, resulting in a decrease in total time from symptom onset to administration of therapy. Figure 1 provides a cumulative distribution plot of time from symptom onset to hospital arrival for GUSTO-I and GUSTO-III separately and with the 2 studies combined. Figure 2 shows the cumulative distribution plot of times from hospital presentation to treatment, reflecting the earlier treatment time for patients in GUSTO-III compared with GUSTO-I. The time from symptom onset to treatment is shorter for patients treated in GUSTO-III compared with GUSTO-I, reflecting reduced inhospital time to treatment; however, the symptom onset to hospital arrival curves are nearly identical for the 2 trials, suggesting no change in patient behavior during the 7-year period in which the 2 trials were conducted (Figure 3). The GUSTO-III data revealed a patient profile similar to GUSTO-I. Increased age, female sex, non-white race, hypertension, and diabetes were all associated with a longer time from onset of symptoms to treatment. Conversely, patients who smoked or had an elevated cholesterol level experienced a shorter total time from onset of symptoms to fibrinolytic therapy. Thirty-day mortality rates in GUSTO-III are comparable with those in GUSTO- I, suggesting that increased time to treatment, for any reason, resulted in increased mortality (Table 3). In GUSTO-III, patient characteristics associated with greater delay in the time from symptom onset to hospital arrival were similar to those in GUSTO-I (Table 3). In GUSTO-III, increased age (64 years versus 60 years; P=.001), female sex (35% versus 27%; P=.001), black race (6% versus 4%; P=.02), and diabetes (25% versus 16%; P=.001) were associated with delay in hospital presentation. Current smokers (46% versus 37%; P=.005) and patients with known coronary artery disease (previous angina [19% versus 14%; P=.006], infarction [19% versus 14%; P=.001], or angioplasty [11% versus 6%; P=.001]) tended to arrive at the hospital earlier. The finding that patients with preexisting angina arrived earlier to hospital in GUSTO-III did not parallel the GUSTO-I results, in which patients with previous angina tended to come to the hospital later. Patients with previous infarction or angioplasty, however, arrived earlier in both GUSTO-I and GUSTO-III. Inhospital and 30-day mortality rates demonstrated that a delay in arrival to the hospital is associated with increased mortality risk (8% versus 5% inhospital, P=.0001; 9% versus 5% 30-day, P=.001). Figure 1. Cumulative distribution plots of time from symptom onset to hospital arrival for the GUSTO-I and GUSTO-III trials. Cumulative distribution (%) 100 Figure 2. Cumulative distribution plots of time from hospital arrival to treatment for the GUSTO-I and GUSTO-III trials. Cumulative distribution (%) GUSTO-I symptom onset to hospital arrival GUSTO-III symptom onset to hospital arrival 20 GUSTO-I hospital arrival to treatment GUSTO-III hospital arrival to treatment Time (h) Time (h) 126 ANNALS OF EMERGENCY MEDICINE 39:2 FEBRUARY 2002

5 When socioeconomic variables were added to this model, black race was no longer retained in the model and was not a significantly indicated risk for out-of-hospital delay. Educational status, however, was now a risk factor for delay in presentation. Patients who had completed college were significantly more likely (30% versus 26%; P=.002) to come to the hospital earlier (median difference 9 minutes) than patients who did not complete high school or who completed high school but not college. Whereas time to treatment inhospital decreased from 1990 to 1997, significant delays in therapy were evident for many patient groups. In GUSTO-III, increased age (64 years versus 60 years; P=.0001), female sex (34% versus 27%; P=.001), black race (7% versus 4%; P=.001), hypertension (48% versus 42%; P=.001), diabetes (21% versus 16%; P=.001), previous angina (46% versus 36%; P=.001), and previous infarction (21% versus 16%; P=.001) were associated with delays in treatment (Table 4). Patients with increased cholesterol levels (43% versus 39%; P=.006) and current smokers (47% versus 38%; P=.001) were treated earlier. Delay in treatment more than 1 hour after hospital arrival was associated with higher mortality rates inhospital (8% versus 4%; P=.001) and at 30 days (9% versus 5%; P=.001). A stepwise regression model combining the US cohorts of GUSTO-I and GUSTO-III identified age, systolic blood pressure, pulse rate, previous infarction, previous bypass surgery, previous angina, sex, race, and infarct location as predictive of time to treatment after hospital arrival. Men were treated 7 minutes faster than women. Patients with previous angina, previous infarction, and previous bypass surgery had delayed therapy (median differences were Table 3. The GUSTO-III trial: Characteristics associated with delay from symptom onset to hospital arrival with associated inhospital, 30- day mortality (early, 0 to 2 hours; late, >4 hours). 0 to 2 Hours 2 to 4 Hours >4 Hours P Characteristic (n=3,087) (n=1,146) (n=324) Value Age, y 60 (50, 70) 64 (53, 73) 64 (55, 74).001 Men Race White Black Diabetes Current smoker Previous angina Previous infarction Previous angioplasty Inhospital mortality Mortality (30 d) Data are median (25th, 75th percentiles) or percentage of patients. P values for comparison of early versus late presenters to hospital. Figure 3. Cumulative distribution plots of time from symptom onset to treatment for the GUSTO-I and GUSTO-III trials Cumulative distribution (%) GUSTO-I symptom onset to treatment GUSTO-III symptom onset to treatment Time (h) Table 4. The GUSTO-III trial: Characteristics associated with delays in treatment after hospital arrival with associated inhospital, 30- day mortality. 0 to 1 Hour >1 Hour P Characteristic (n=3,034) (n=1,514) Value Age, y 60 (51, 70) 64 (53, 73).0001 Men Race White Black Hypertension Diabetes Hypercholesterolemia Current smoker Previous angina Previous infarction Inhospital mortality Mortality (30 d) Data are median (25th, 75th percentiles) or percentage of patients. P values for comparison of patients treated in the first hour after hospital arrival versus later. FEBRUARY :2 ANNALS OF EMERGENCY MEDICINE 127

6 5.5, 4.8, and 6.0 minutes, respectively). Older patients were treated later, as were black patients (median delay of 12 minutes). Patients with inferior and anterior infarcts were treated 15 minutes earlier than patients with other infarct sites. Using GUSTO-III s socioeconomic data, we developed a new model containing the predictive factors of pulse rate, sex, previous angina, black race, infarct location, and whether the patient received public insurance. Patients with public insurance were treated, on average, 6 minutes later than those with private insurance. Patients with higher educational levels had decreased time from symptom onset to hospital arrival (30% versus 26%; P=.001; Table 5), as did individuals with management or professional occupations (28% versus 21%; P=.001). Having private insurance was associated with an earlier response to symptoms of AMI (64% versus 56%; P=.003), whereas patients with public insurance arrived later (36% versus 44%; P=.001). Living alone also resulted in a later arrival to the hospital compared with patients living with family or friends (18% versus 23%; P=.006). Patients with at least a high school education were treated sooner once in the emergency setting than those without this degree (Table 6). Homemakers or housewives received delayed treatment (9% versus 12%; P=.004), whereas individuals with a management or professional background experienced more rapid treatment (24% versus 23%; P=.026). Private insurance was associated with more rapid delivery of therapy inhospital (65% versus 58%; P=.001), whereas patients with public insurance tended to have delays in therapy (36% versus 45%; P=.001). Individuals without insurance were treated earlier as well (8% versus 6%; P=.013). DISCUSSION Early treatment of patients with AMI is critical to maximizing benefit Our study sought to identify factors associated with delays to hospital arrival as well as inhospital administration of thrombolytic therapy. In the GUSTO-I and GUSTO-III trials, the median time of delay from symptom onset to hospital arrival was 1.4 hours. During the 7 years between these 2 studies, despite widespread knowledge of the benefits of thrombolytic therapy among health care providers and extensive public education programs about AMI, early arrival to the hospital and treatment once in the hospital have not been realized. In particular, the same groups identified in a previous study Table 5. Socioeconomic factors associated with patient delays from symptom onset to hospital arrival. 0 to 2 Hours 2 to 4 Hours >4 Hours P Socioeconomic Factor (n=3,087) (n=1,146) (n=324) Value High school completed College/university completed Years of school completed 12 (12, 14) 12 (11, 13) 12 (11, 14) NS Current/principal past occupation Clerical/sales NS Craftsman NS Homemaker/housewife NS Laborer NS Management/professional Type of insurance Private Public Other NS None NS Lives alone NS, Not significant. Data are median (25th, 75th percentiles) or percentage of patients. P values for comparison of early versus late presenters to hospital. Table 6. Socioeconomic factors associated with delays in treatment after hospital arrival. 0 to 1 Hour >1 Hour P Socioeconomic Factor (n=3,034) (n=1,514) Value High school completed College/university completed NS Years of school completed 12 (12, 14) 12 (11, 14) NS Current/principal past occupation Clerical/sales NS Craftsman 9 8 NS Homemaker/housewife Laborer NS Management/professional Type of insurance Private Public Other 2 2 NS None Lives alone NS NS, Not significant. Data are median (25th, 75th percentiles) or percentage of patients. P values for comparison of patients treated in the first hour after hospital arrival versus later. 128 ANNALS OF EMERGENCY MEDICINE 39:2 FEBRUARY 2002

7 of GUSTO-I (conducted from 1990 through 1993) as susceptible to delay (elderly, women, patients with diabetes, and minorities) continue to arrive late to the hospital. 5 Other studies have confirmed that these patients are at risk for delay Education of patients identified as having increased risk for development of atherosclerosis and subsequent myocardial infarction would appear prudent. 18 The National Heart, Lung, and Blood Institute, through the National Heart Attack Alert Program, has supported educational initiatives through a mass media project: Rapid Early Action for Coronary Treatment (REACT). 19 Targeting such patients individually, through their family physician or pharmacist, may be more effective than mass media projects, which may not provide focus for patients at high risk. It would appear that some benefit of education was obtained in the years between the 2 trials for patients with previous angina. Although patients with pre-existing angina experienced a delay in hospital presentation in GUSTO I, this was not observed in GUSTO III. Ten years ago, initial studies evaluating time to treatment once the patient arrived at the hospital identified a typical 90-minute delay before infusion of fibrinolytic therapy. 20,21 Although substantial progress has been realized since then, national registries still identify delays of nearly 40 minutes. 4 In GUSTO-I, initiated in 1990, the median time from hospital arrival to treatment was 66 minutes. This period had decreased to 48 minutes when measured in GUSTO-III, which was completed 7 years later. Patients with previous angina, infarction, and angioplasty tended to present to the hospital earlier with AMI. Paradoxically, these patients with known coronary artery disease tended to have delays in delivery of fibrinolytic therapy. There are multiple possible reasons for this inhospital delay in therapy. Patients presenting with preexisting coronary artery disease often have baseline electrocardiographic abnormalities that can confound the diagnosis of an acute injury. Typically, the old ECG or the patient s medical records, which describe a previous procedure or hospitalization, must then be obtained from another area of the institution or from another hospital system entirely; this can serve as a significant source of delay in diagnosis. In a similar fashion, contacting the patient s primary care physician or cardiologist for consultation while the patient is in the ED is often necessary for these patients and can also retard treatment. One finding of this study was that certain groups of patients are especially prone to experience inhospital treatment delays. Among these are patient subgroups at risk for out-of-hospital delay as well, including the elderly, women, minorities, and patients with diabetes. 5,13,22 Although multiple studies have identified female patients as prone to delays in therapy, 13,18 the other groups have received less attention. Elderly patients with diabetes are known to have atypical symptoms associated with AMI. 23,24 These less typical symptoms serve to confound the clinician in the emergency setting caring for these patients, thus increasing the likelihood of a delay in diagnosis and treatment once the patient arrives at the hospital. Further education of health care providers is essential to prospectively identify these high-risk groups and subsequently to pursue approaches to decrease time to treatment for these patients. The GUSTO-III study prospectively identified the influence of socioeconomic factors on time to hospital arrival and time to treatment. A patient s educational level, occupation, health insurance, and the presence of family or friends in the home appear to affect health careseeking behavior. Health care provider behavior appears to be influenced as well. A higher educational level and occupations defined as management or professional are associated with earlier times to hospital arrival and treatment. The more highly educated patient may be aware of the symptoms and risk factors associated with AMI, prompting earlier hospital arrival. Once in hospital, the patient with a higher educational level may better articulate this symptom complex, allowing the treating physician to make a more rapid decision. Similarly, in patients with symptoms of myocardial infarction, having private health insurance is linked with earlier arrival to the hospital and more rapid administration of fibrinolytic therapy compared with public insurance Living alone also led to a delay in arrival, perhaps as a result of the lack of family or friends necessary to convince a patient of the severity or importance of their symptoms. Other factors, such as education level, availability of a telephone, or income level could also influence the behavior of the patient living alone. This study evaluating nearly 28,000 patients with myocardial infarction treated in the United States during the GUSTO-I and GUSTO-III trials identifies a number of patients at risk for not receiving thrombolytic therapy early in the course of their infarction. Significant delays in hospital arrival and treatment still exist nearly a decade after the original GUSTO-I trial, suggesting that further effort is necessary to educate patients and health care providers. Although special educational efforts should be targeted to those individuals known to be at high risk for delays in hospital arrival and treatment, such as women, FEBRUARY :2 ANNALS OF EMERGENCY MEDICINE 129

8 the elderly, and those with less formal education, patients who are not members of these particular groups also suffer delays and require education about AMI. 28 The timedependent nature of thrombolytic treatment for myocardial infarction represents a critical public health education challenge. Biostatistical information is included in the full-text, online version of this article. Access the Annals Web site at Information is also available at ACEP s home page at Author contributions: WBG, PWA, EMO, and WDW conceived the study, designed the analysis, and supervised the conduct of the study. ALS and RMC managed the data and provided data analyses. JMG and LKN helped to recruit centers, enroll patients, and manage data. RMC and EJT obtained research funding for the trial, conceived of the primary trial, and recruited sites. WBG drafted the manuscript and all authors contributed substantially to its revision. WBG takes ultimate responsibility for the paper as a whole. REFERENCES 1. Gruppo Italiano per lo Studio della Streptochinasi nell Infarto miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet. 1986;1: Fibrinolytic Therapy Trialist s (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1,000 patients. Lancet. 1994;343: National Heart Attack Alert Program Coordinating Committee, 60 Minutes to Treatment Working Group. Rapid identification and treatment of acute myocardial infarction in the emergency department. Ann Emerg Med. 1994;23: Rogers WJ, Bowlby LJ, Chandra N, et al. Treatment of myocardial infarction in the United States ( ). Circulation. 1994;90: Newby LK, Rutsch WR, Califf RM, et al. Time from symptom onset to treatment and outcomes after thrombolytic therapy. J Am Coll Cardiol. 1996;27: The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 1993;329: The GUSTO III Investigators. A comparison of reteplase with alteplase for acute myocardial infarction. N Engl J Med. 1997;337: Weaver WD. Time to thrombolytic treatment: factors affecting delay and their influence on outcome. J Am Coll Cardiol. 1995;25: Rawles J. Halving of mortality at 1 year by domiciliary thrombolysis in the Grampian Region Early Anistreplase Trial (GREAT). J Am Coll Cardiol. 1994;23: Weaver WD, Cerqueira M, Hallstrom AP, et al. Prehospital-initiated versus hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial. JAMA. 1993;270: Malacrida R, Genoni M, Maggioni AP, et al. A comparison of the early outcome of acute myocardial infarction in women and men. N Engl J Med. 1998;338: Burnet RE, Blumenthal JA, Mark DB, et al. Distinguishing between early and late responders to symptoms of acute myocardial infarction. Am J Cardiol. 1995;75: Chaturvedi N, Rai H, Ben-Shlomo U. Lay diagnosis and health-care-seeking behavior for chest pain in South Asians and Europeans. Lancet. 1997;350: Weaver WD, White HD, Wilcox RG, et al. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. JAMA. 1996;275: Cooper RS, Simmons B, Castaner A, et al. Survival rates and prehospital delay during myocardial infarction among black persons. Am J Cardiol. 1986;57: Chandra NC, Ziegelstein RC, Rogers WJ, et al. Observations of the treatment of women in the United States with myocardial infarction. Arch Intern Med. 1998;158: Lambrew CT, Bowlby LJ, Rogers WJ, et al. Factors influencing the time to thrombolysis in acute myocardial infarction. Arch Intern Med. 1997;157: Ho MT, Eisenberg MS, Litwin PE, et al. Delay between onset of chest pain and seeking medical care: the effect of public education. Ann Emerg Med. 1989;18: Luepker RV. Reducing prehospital patient related delays. Paper presented at: American Heart Association Meeting Plenary Session; November 9, 1998; Dallas, TX. 20. Kereiakes DJ, Weaver WD, Anderson JI, et al. Time delays in the diagnosis and treatment of acute myocardial infarction: a tale of eight cities. Report from the Pre-hospital Study Group and the Cincinnati Heart Project. Am Heart J. 1990;120: Gibler WB, Kereiakes DJ, Dean EN, et al. Prehospital diagnosis and treatment of acute myocardial infarction: a North-South perspective. Am Heart J. 1991;121: Schulman KA, Berlin JA, Harless W, et al. The effect of race and sex on physicians recommendations for cardiac catheterization. N Engl J Med. 1999;340: Bayer AJ, Chadha JS, Farag RR, et al. Changing presentation of myocardial infarction with increasing old age. J Am Geriatr Soc. 1986;34: Margolis JR, Kannel WB, Feinlab M, et al. Clinical features of unrecognized myocardial infarction: silent and asymptomatic. Eighteen-year follow-up: the Framingham Study. Am J Cardiol. 1973;32: Magid DJ, Koepsell TD, Every NR, et al. Absence of association between insurance copayments and delays in seeking emergency care among patients with myocardial infarction. N Engl J Med. 1997;336: Sada MJ, French WJ, Carlisle DM, et al. Influence of payer on use of invasive cardiac procedures and patient outcome after myocardial infarction in the United States. J Am Coll Cardiol. 1998;31: Picken HA, Zucker DR, Griffith JL, et al. Insurance type and the transportation to emergency departments of patients with acute cardiac ischemia: the ACI-TIPI trial insurance study. Am J Manag Care. 1998; Pope JH, Aufderheide TP, Ruthazer R, et al. Missed diagnoses of acute cardiac ischemia in the emergency department. N Engl J Med. 2000;342: ANNALS OF EMERGENCY MEDICINE 39:2 FEBRUARY 2002

Journal of the American College of Cardiology Vol. 37, No. 6, by the American College of Cardiology ISSN /01/$20.

Journal of the American College of Cardiology Vol. 37, No. 6, by the American College of Cardiology ISSN /01/$20. Journal of the American College of Cardiology Vol. 37, No. 6, 2001 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00 Published by Elsevier Science Inc. PII S0735-1097(01)01198-6 Consequences

More information

Time delays in instituting thrombolysis in acute myocardial infarction - a Singapore perspective

Time delays in instituting thrombolysis in acute myocardial infarction - a Singapore perspective Hong Kong Journal of Emergency Medicine Time delays in instituting thrombolysis in acute myocardial infarction - a Singapore perspective M Tiru and SH Goh The reduction of mortality from acute myocardial

More information

In-hospital Mortality with Relation to Time of Presentation in Patients with Acute ST Elevation Myocardial Infarction

In-hospital Mortality with Relation to Time of Presentation in Patients with Acute ST Elevation Myocardial Infarction ORIGINAL ARTICLE In-hospital Mortality with Relation to Time of Presentation in Patients with Acute ST Elevation Myocardial Infarction ABDUL SATTAR, ABDUL BARI, MOAZAM ALI NAQVI, AHMAD NOEMAN ABSTRACT

More information

A community hospital s effort to expedite treatment for patients with chest pain

A community hospital s effort to expedite treatment for patients with chest pain A community hospital s effort to expedite treatment for patients with chest pain By: Holly Griffin, Leslie L. Davis, Edna Gant, Michael Savona, Linda Shaw, James Strickland, Cindy Wood, and Galen Wagner

More information

A Report From the Second National Registry of Myocardial Infarction (NRMI-2)

A Report From the Second National Registry of Myocardial Infarction (NRMI-2) 1240 JACC Vol. 31, No. 6 Clinical Experience With Primary Percutaneous Transluminal Coronary Angioplasty Compared With Alteplase (Recombinant Tissue-Type Plasminogen Activator) in Patients With Acute Myocardial

More information

Journal of the American College of Cardiology Vol. 35, No. 4, by the American College of Cardiology ISSN /00/$20.

Journal of the American College of Cardiology Vol. 35, No. 4, by the American College of Cardiology ISSN /00/$20. Journal of the American College of Cardiology Vol. 35, No. 4, 2000 2000 by the American College of Cardiology ISSN 0735-1097/00/$20.00 Published by Elsevier Science Inc. PII S0735-1097(99)00643-9 Early

More information

ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (STEMI): DECREASING THE TIME TO TREATMENT IN THE ED

ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (STEMI): DECREASING THE TIME TO TREATMENT IN THE ED ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (STEMI): DECREASING THE TIME TO TREATMENT IN THE ED W. Brian Gibler, MD Professor and Chairman; Department of Emergency Medicine, University of Cincinnati College

More information

Emergency physician versus cardiologistinitiated thrombolysis for acute myocardial infarction: a Singapore experience

Emergency physician versus cardiologistinitiated thrombolysis for acute myocardial infarction: a Singapore experience O r i g i n a l A r t i c l e Singapore Med J 2004 Vol 45(7) : 313 Emergency physician versus cardiologistinitiated thrombolysis for acute myocardial infarction: a Singapore experience I Irwani, C M Seet,

More information

Influence of Treatment Delay on Infarct Size and Clinical Outcome in Patients With Acute Myocardial Infarction Treated With Primary Angioplasty

Influence of Treatment Delay on Infarct Size and Clinical Outcome in Patients With Acute Myocardial Infarction Treated With Primary Angioplasty 629 Influence of Treatment Delay on Infarct Size and Clinical Outcome in Patients With Acute Myocardial Infarction Treated With Primary Angioplasty AYLEE L. LIEM, MD, ARNOUD W.J. VAN T HOF, MD, JAN C.A.

More information

Improving the Outcomes of

Improving the Outcomes of Improving the Outcomes of STEMI Shelley Valaire, ACP; and Robert Welsh, MD, FRCPC Presented at the University of Alberta s 6th Annual Cardiology Update for General Practitioners and Internists, Edmonton,

More information

Lack of progress in cardiogenic shock: lessons from the GUSTO trials

Lack of progress in cardiogenic shock: lessons from the GUSTO trials European Heart Journal (2000) 21, 1928 1936 doi:10.1053/euhj.2000.2240, available online at http://www.idealibrary.com on Lack of progress in cardiogenic shock: lessons from the GUSTO trials V. Menon 1,

More information

Myocardial infarction (MI) is the single largest killer of

Myocardial infarction (MI) is the single largest killer of Use of Emergency Medical Services in Acute Myocardial Infarction and Subsequent Quality of Care Observations From the National Registry of Myocardial Infarction 2 John G. Canto, MD, MSPH; Robert J. Zalenski,

More information

A. W. J. van t Hof, A. Liem, H. Suryapranata, J. C. A. Hoorntje, M.-J de Boer and F. Zijlstra

A. W. J. van t Hof, A. Liem, H. Suryapranata, J. C. A. Hoorntje, M.-J de Boer and F. Zijlstra European Heart Journal (1998) 19, 118 123 Clinical presentation and outcome of patients with early, intermediate and late reperfusion therapy by primary coronary angioplasty for acute myocardial infarction

More information

Risk Stratification of ACS Patients. Frans Van de Werf, MD, PhD University of Leuven, Belgium

Risk Stratification of ACS Patients. Frans Van de Werf, MD, PhD University of Leuven, Belgium Risk Stratification of ACS Patients Frans Van de Werf, MD, PhD University of Leuven, Belgium Which type of ACS patients are we talking about to day? 4/14/2011 STEMI and NSTEMI in the NRMI registry from

More information

Journal of the American College of Cardiology Vol. 33, No. 2, by the American College of Cardiology ISSN /99/$20.

Journal of the American College of Cardiology Vol. 33, No. 2, by the American College of Cardiology ISSN /99/$20. Journal of the American College of Cardiology Vol. 33, No. 2, 1999 1999 by the American College of Cardiology ISSN 0735-1097/99/$20.00 Published by Elsevier Science Inc. PII S0735-1097(98)00579-8 Effect

More information

Effects of Stroke on Medical Resource Use and Costs in Acute Myocardial Infarction

Effects of Stroke on Medical Resource Use and Costs in Acute Myocardial Infarction Effects of Stroke on Medical Resource Use and Costs in Acute Myocardial Infarction Chen Y. Tung, MD; Christopher B. Granger, MD; Michael A. Sloan, MD; Eric J. Topol, MD; J. David Knight, MS; W. Douglas

More information

Impact of Delay in Door-to-Needle Time on Mortality in Patients With ST-Segment Elevation Myocardial Infarction

Impact of Delay in Door-to-Needle Time on Mortality in Patients With ST-Segment Elevation Myocardial Infarction Impact of Delay in Door-to-Needle Time on Mortality in Patients With ST-Segment Elevation Myocardial Infarction Robert L. McNamara, MD, MHS a, Jeph Herrin, PhD a, Yongfei Wang, MS a, Jeptha P. Curtis,

More information

Medical Error Prevention in ED Triage for ACS: Use of Cardiac Care Decision Support and Quality Improvement Feedback

Medical Error Prevention in ED Triage for ACS: Use of Cardiac Care Decision Support and Quality Improvement Feedback Cardiol Clin 23 (2005) 601 614 Medical Error Prevention in ED Triage for ACS: Use of Cardiac Care Decision Support and Quality Improvement Feedback Denise H. Daudelin, RN, MPH a,b, Harry P. Selker, MD,

More information

In the treatment of acute myocardial infarction (AMI), 1 3 restoring coronary perfusion

In the treatment of acute myocardial infarction (AMI), 1 3 restoring coronary perfusion BACK OF THE ENVELOPE DAVID M. KENT, MD JOSEPH LAU, MD HARRY P. SELKER, MD, MSPH New England Medical Center Tufts University School of Medicine Boston, Mass Eff Clin Pract. 2001;4:214-220. Balancing the

More information

The restoration of coronary flow after an

The restoration of coronary flow after an Pharmacological Reperfusion in Acute Myicardial Infarction after ASSENT 3 and GUSTO V [81] DANIEL FERREIRA, MD, FESC Serviço de Cardiologia, Hospital Fernando Fonseca, Amadora, Portugal Rev Port Cardiol

More information

The First 12 Hours. ST-Segment Elevation AMI: Introduction. Definitions

The First 12 Hours. ST-Segment Elevation AMI: Introduction. Definitions ST-Segment Elevation AMI: The First 12 Hours Acute myocardial infarction (AMI) accounts for half of the deaths due to ischemic heart disease and is associated with significant use of resources. Because

More information

PRIMARY CORONARY ANGIOPLASTY VERSUS INTRAVENOUS THROMBOLYSIS FOR ACUTE MYOCARDIAL INFARCTION - A COMPARATIVE STUDY AT QUEEN ALIA HEART INSTITUTE

PRIMARY CORONARY ANGIOPLASTY VERSUS INTRAVENOUS THROMBOLYSIS FOR ACUTE MYOCARDIAL INFARCTION - A COMPARATIVE STUDY AT QUEEN ALIA HEART INSTITUTE PRIMARY CORONARY ANGIOPLASTY VERSUS INTRAVENOUS THROMBOLYSIS FOR ACUTE MYOCARDIAL INFARCTION - A COMPARATIVE STUDY AT QUEEN ALIA HEART INSTITUTE Walid Sawalha MD, MBBS (Lond), MRCP(UK)* ABSTRACT Objectives:

More information

ACUTE MYOCARDIAL INFARCtion

ACUTE MYOCARDIAL INFARCtion ORIGINAL CONTRIBUTION Primary Coronary Angioplasty vs for the Management of Acute Myocardial Infarction in Elderly Patients Alan K. Berger, MD Kevin A. Schulman, MD Bernard J. Gersh, MB, ChB, DPhil Sarmad

More information

TAB 7: SUB TAB: AMI/CHEST PAIN Specifications & Paper Tools

TAB 7: SUB TAB: AMI/CHEST PAIN Specifications & Paper Tools TAB 7: SUB TAB: AMI/CHEST PAIN Specifications & Paper Tools Material inside brackets ([and]) is new to this Specifications Manual version. Hospital Outpatient Quality Measures Acute Myocardial Infarction

More information

Despite a significant reduction in the overall age-adjusted mortality rates due

Despite a significant reduction in the overall age-adjusted mortality rates due Age-related differences in in-hospital mortality and the use of thrombolytic therapy for acute myocardial infarction Jean-Marc Boucher, * Normand Racine, Thao Huynh Thanh, Elham Rahme, James Brophy, *

More information

Thrombolysis in acute myocardial infarction: analysis of studies comparing accelerated t-pa and streptokinase

Thrombolysis in acute myocardial infarction: analysis of studies comparing accelerated t-pa and streptokinase 3'Accid Emerg Med 1999;16:407-41 1 Thrombolysis in acute myocardial infarction: analysis of studies comparing accelerated t-pa and streptokinase Brendon J Smith 407 Department of Emergency Medicine, Sutherland

More information

Prehospital management of acute ST-elevation myocardial infarction: A time for reappraisal in North America

Prehospital management of acute ST-elevation myocardial infarction: A time for reappraisal in North America Progress in Cardiology Prehospital management of acute ST-elevation myocardial infarction: A time for reappraisal in North America Robert C. Welsh, MD, a Joseph Ornato, MD, b and Paul W. Armstrong, MD

More information

Critical Review Form Therapy Objectives: Methods:

Critical Review Form Therapy Objectives: Methods: Critical Review Form Therapy Clinical Trial Comparing Primary Coronary Angioplasty with Tissue-Plasminogen Activator for Acute Myocardial Infarction (GUSTO-IIb), NEJM 1997; 336: 1621-1628 Objectives: To

More information

Impaired Chronotropic Response to Exercise Stress Testing in Patients with Diabetes Predicts Future Cardiovascular Events

Impaired Chronotropic Response to Exercise Stress Testing in Patients with Diabetes Predicts Future Cardiovascular Events Diabetes Care Publish Ahead of Print, published online May 28, 2008 Chronotropic response in patients with diabetes Impaired Chronotropic Response to Exercise Stress Testing in Patients with Diabetes Predicts

More information

The development of cardiogenic shock portends an extremely poor prognosis. Cardiogenic Shock: A Lethal Complication of Acute Myocardial Infarction

The development of cardiogenic shock portends an extremely poor prognosis. Cardiogenic Shock: A Lethal Complication of Acute Myocardial Infarction TREATMENT UPDATE Cardiogenic Shock: A Lethal Complication of Acute Myocardial Infarction David R. Holmes, Jr, MD Mayo Graduate School of Medicine, Mayo Clinic, Rochester, MN Cardiogenic shock is a serious

More information

Sustained Benefit 20 Years After Reperfusion Therapy in Acute Myocardial Infarction

Sustained Benefit 20 Years After Reperfusion Therapy in Acute Myocardial Infarction Journal of the American College of Cardiology Vol. 46, No. 1, 2005 2005 by the American College of Cardiology Foundation ISSN 0735-1097/05/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.03.047

More information

OUTCOME OF THROMBOLYTIC AND NON- THROMBOLYTIC THERAPY IN ACUTE MYOCARDIAL INFARCTION

OUTCOME OF THROMBOLYTIC AND NON- THROMBOLYTIC THERAPY IN ACUTE MYOCARDIAL INFARCTION OUTCOME OF THROMBOLYTIC AND NON- THROMBOLYTIC THERAPY IN ACUTE MYOCARDIAL INFARCTION FEROZ MEMON*, LIAQUAT CHEEMA**, NAND LAL RATHI***, RAJ KUMAR***, NAZIR AHMED MEMON**** OBJECTIVE: To compare morbidity,

More information

Utilization and Impact of Pre-Hospital Electrocardiograms for Patients With Acute ST-Segment Elevation Myocardial Infarction

Utilization and Impact of Pre-Hospital Electrocardiograms for Patients With Acute ST-Segment Elevation Myocardial Infarction Journal of the American College of Cardiology Vol. 53, No. 2, 2009 2009 by the American College of Cardiology Foundation ISSN 0735-1097/09/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2008.09.030

More information

ORIGINAL INVESTIGATION. Early Clinical Outcomes and Routine Management of Patients With Non ST-Segment Elevation Myocardial Infarction

ORIGINAL INVESTIGATION. Early Clinical Outcomes and Routine Management of Patients With Non ST-Segment Elevation Myocardial Infarction Early Clinical Outcomes and Routine Management of Patients With Non ST-Segment Elevation Myocardial Infarction A Nationwide Perspective ORIGINAL INVESTIGATION Richard C. Becker, MD; Maureen Burns, MD;

More information

Optimizing primary percutaneous coronary intervention in ST-segment elevation myocardial infarction

Optimizing primary percutaneous coronary intervention in ST-segment elevation myocardial infarction EDITORIAL Optimizing primary percutaneous coronary intervention in ST-segment elevation myocardial infarction In an ideal world, all patients with [ST-segment elevation myocardial infarction] would be

More information

Inter-regional differences and outcome in unstable angina

Inter-regional differences and outcome in unstable angina European Heart Journal (2000) 21, 1433 1439 doi:10.1053/euhj.1999.1983, available online at http://www.idealibrary.com on Inter-regional differences and outcome in unstable angina Analysis of the International

More information

The New England Journal of Medicine. Special Articles OUTCOME OF ACUTE MYOCARDIAL INFARCTION ACCORDING TO THE SPECIALTY OF THE ADMITTING PHYSICIAN

The New England Journal of Medicine. Special Articles OUTCOME OF ACUTE MYOCARDIAL INFARCTION ACCORDING TO THE SPECIALTY OF THE ADMITTING PHYSICIAN Special Articles OUTCOME OF ACUTE MYOCARDIAL INFARCTION ACCORDING TO THE SPECIALTY OF THE ADMITTING PHYSICIAN JAMES G. JOLLIS, M.D., ELIZABETH R. DELONG, PH.D., ERIC D. PETERSON, M.D., M.P.H., LAWRENCE

More information

Acute Myocardial Infarction: Difference in the Treatment between Men and Women

Acute Myocardial Infarction: Difference in the Treatment between Men and Women Quality Assurance in Hcahh Can, Vol. 5, No. 3, pp. 261-265,1993 Printed in Great Britain 1040-6166/93 $6.00 + 0.00 1993 Pergamon Press Ltd Acute Myocardial Infarction: Difference in the Treatment between

More information

Journal of the American College of Cardiology Vol. 36, No. 5, by the American College of Cardiology ISSN /00/$20.

Journal of the American College of Cardiology Vol. 36, No. 5, by the American College of Cardiology ISSN /00/$20. Journal of the American College of Cardiology Vol. 36, No. 5, 2000 2000 by the American College of Cardiology ISSN 0735-1097/00/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)00897-4 A Randomized

More information

Quality Improvement Report

Quality Improvement Report Quality in Health Care 1994;2:29-33 29 Accident and Emergency Department, Stockport Infirmary, Stockport SKI 3UJ Patrick A Nee, senior registrar Alistair J Gray, consultant Stepping Hill Hospital, Poplar

More information

Current Advances and Best Practices in Acute STEMI Management A pharmacoinvasive approach

Current Advances and Best Practices in Acute STEMI Management A pharmacoinvasive approach Current Advances and Best Practices in Acute STEMI Management A pharmacoinvasive approach Frans Van de Werf, MD, PhD University Hospitals, Leuven, Belgium Frans Van de Werf: Disclosures Research grants

More information

Journal of the American College of Cardiology Vol. 39, No. 11, by the American College of Cardiology Foundation ISSN /02/$22.

Journal of the American College of Cardiology Vol. 39, No. 11, by the American College of Cardiology Foundation ISSN /02/$22. Journal of the American College of Cardiology Vol. 39, No. 11, 2002 2002 by the American College of Cardiology Foundation ISSN 0735-1097/02/$22.00 Published by Elsevier Science Inc. PII S0735-1097(02)01856-9

More information

American Medical Women s Association Position Paper on Principals of Women & Coronary Heart Disease

American Medical Women s Association Position Paper on Principals of Women & Coronary Heart Disease American Medical Women s Association Position Paper on Principals of Women & Coronary Heart Disease AMWA is a leader in its dedication to educating all physicians and their patients about heart disease,

More information

Thrombolytic effect of streptokinase infusion assessed by ST-segment resolution between diabetic and non-diabetic myocardial infarction patients

Thrombolytic effect of streptokinase infusion assessed by ST-segment resolution between diabetic and non-diabetic myocardial infarction patients ORIGINAL ARTICLE Cardiology Journal 2012, Vol. 19, No. 2, pp. 168 173 10.5603/CJ.2012.0029 Copyright 2012 Via Medica ISSN 1897 5593 Thrombolytic effect of streptokinase infusion assessed by ST-segment

More information

PCI Strategies After Fibrinolytic Therapy

PCI Strategies After Fibrinolytic Therapy PCI Strategies After Fibrinolytic Therapy How to choose the appropriate reperfusion strategy. BY MICHEL R. LE MAY, MD Survival in patients presenting with ST-segment elevation myocardial infarction (STEMI)

More information

When the learner has completed this module, she/he will be able to:

When the learner has completed this module, she/he will be able to: Thrombolytics and Myocardial Infarction WWW.RN.ORG Reviewed September 2017, Expires September 2019 Provider Information and Specifics available on our Website Unauthorized Distribution Prohibited 2017

More information

Tobacco Consumption and Acute Myocardial Infarction

Tobacco Consumption and Acute Myocardial Infarction Home SVCC Area: English - Español - Português Tobacco Consumption and Acute Myocardial Infarction Bianco, Eduardo; Cobas, Joaquín Cardiac Care Unit (CCU), Asociación Española Primera de Socorros Mutuos.

More information

Which Patients With Suspected Myocardial Ischemia and Left Bundle-Branch Block Should Receive Thrombolytic Agents?

Which Patients With Suspected Myocardial Ischemia and Left Bundle-Branch Block Should Receive Thrombolytic Agents? EDITORIAL: Which Patients With Suspected Myocardial Ischemia and Left Bundle-Branch Block Should Receive Thrombolytic Agents? From the Department of Emergency Medicine, Albert Einstein College of Medicine,

More information

THE emergency physician (EP), frequently the

THE emergency physician (EP), frequently the 1256 ST-SEGMENT ELEVATION Brady et al. INTERPRETATION OF ST-SEGMENT ELEVATION Errors in Emergency Physician Interpretation of ST-segment Elevation in Emergency Department Chest Pain Patients WILLIAM J.

More information

Post-Reteplase Evaluation of Clinical Safety & Efficacy in Indian Patients (Precise-In Study)

Post-Reteplase Evaluation of Clinical Safety & Efficacy in Indian Patients (Precise-In Study) 30 Post-Reteplase Evaluation of Clinical Safety & Efficacy in Indian Patients (Precise-In Study) RK Singh 1, A Trailokya 2, MM Naik 3 Original Article Abstract Background: ST elevated myocardial infarction

More information

Hospital and 1-year outcome after acute myocardial infarction in patients with diabetes mellitus and hypertension

Hospital and 1-year outcome after acute myocardial infarction in patients with diabetes mellitus and hypertension (2003) 17, 665 670 & 2003 Nature Publishing Group All rights reserved 0950-9240/03 $25.00 www.nature.com/jhh ORIGINAL ARTICLE Hospital and 1-year outcome after acute myocardial infarction in patients with

More information

Abortion of acute ST segment elevation myocardial infarction after reperfusion: incidence, patients characteristics, and prognosis

Abortion of acute ST segment elevation myocardial infarction after reperfusion: incidence, patients characteristics, and prognosis 496 CARDIOVASCULAR MEDICINE Abortion of acute ST segment elevation myocardial infarction after reperfusion: incidence, patients characteristics, and prognosis E J P Lamfers, T E H Hooghoudt, D P Hertzberger,

More information

Stress ECG is still Viable in Suleiman M Kharabsheh, MD, FACC Consultant Invasive Cardiologist KFHI KFSHRC-Riyadh

Stress ECG is still Viable in Suleiman M Kharabsheh, MD, FACC Consultant Invasive Cardiologist KFHI KFSHRC-Riyadh Stress ECG is still Viable in 2016 Suleiman M Kharabsheh, MD, FACC Consultant Invasive Cardiologist KFHI KFSHRC-Riyadh Stress ECG Do we still need stress ECG with all the advances we have in the CV field?

More information

ST-elevation myocardial infarctions (STEMIs)

ST-elevation myocardial infarctions (STEMIs) Guidelines for Treating STEMI: Case-Based Questions As many as 25% of eligible patients presenting with STEMI do not receive any form of reperfusion therapy. The ACC/AHA guidelines highlight steps to improve

More information

A. BISOC 1,2 A.M. PASCU 1 M. RĂDOI 1,2

A. BISOC 1,2 A.M. PASCU 1 M. RĂDOI 1,2 Bulletin of the Transilvania University of Braşov Series VI: Medical Sciences Vol. 5 (54) No. 2-2012 THE ctntg4 PLASMA LEVELS IN RELATION TO ELECTROCARDIOGRAPHIC AND ECHOCARDIOGRAPHIC ABNORMALITIES IN

More information

Predictors of inhospital outcome after acute inferior wall myocardial infarction

Predictors of inhospital outcome after acute inferior wall myocardial infarction 956 Original Article Predictors of inhospital outcome after acute inferior wall myocardial infarction Jim M H, Chan A O, Tse H F, Lau C P Cardiac Medical Unit, Grantham Hospital, 125 Wong Chuk Hang Road,

More information

Can Myocardial Infarction Be Rapidly Identified in Emergency Department Patients Who Have Left Bundle-Branch Block?

Can Myocardial Infarction Be Rapidly Identified in Emergency Department Patients Who Have Left Bundle-Branch Block? ORIGINAL CONTRIBUTION Can Myocardial Infarction Be Rapidly Identified in Emergency Department Patients Who Have Left Bundle-Branch Block? From the Department of Internal Medicine, Division of Cardiology,

More information

Regional STEMI Transfer Systems: the Mayo and NC RACE Experiences

Regional STEMI Transfer Systems: the Mayo and NC RACE Experiences Regional STEMI Transfer Systems: the Mayo and NC RACE Experiences Dr. Henry H. Ting, Mayo Clinic College of Medicine Dr. James G. Jollis,, Duke University Medical Center Mayo Clinic STEMI System for Transferred

More information

OP Chest Pain General Data Element List. All Records All Records. All Records All Records All Records. All Records. All Records.

OP Chest Pain General Data Element List. All Records All Records. All Records All Records All Records. All Records. All Records. Material inside brackets ([and]) is new to this Specifications Manual version. Hospital Outpatient Quality Measures Chest Pain (CP) Set Measure ID # OP-4 * OP-5 * Measure Short Name Aspirin at Arrival

More information

Clinical Difference Between a Thoracic Aortic Dissection and an Acute Myocardial Infarction. Myeong Hee Kang M.D., Kab Teug Kim M.D.

Clinical Difference Between a Thoracic Aortic Dissection and an Acute Myocardial Infarction. Myeong Hee Kang M.D., Kab Teug Kim M.D. 516 / = Abstract = Clinical Difference Between a Thoracic Aortic Dissection and an Acute Myocardial Infarction Myeong Hee Kang M.D., Kab Teug Kim M.D. Department of Emergence medicine, Dankook University

More information

SUPPLEMENTAL MATERIAL. Supplemental Methods. Duke CAD Index

SUPPLEMENTAL MATERIAL. Supplemental Methods. Duke CAD Index SUPPLEMENTAL MATERIAL Supplemental Methods Duke CAD Index The Duke CAD index, originally developed by David F. Kong, is an angiographic score that hierarchically assigns prognostic weights (0-100) based

More information

Patient characteristics Intervention Comparison Length of followup

Patient characteristics Intervention Comparison Length of followup ISCHAEMIA TESTING CHAPTER TESTING FOR MYCOCARDIAL ISCHAEMIA VERSUS NOT TESTING FOR MYOCARDIAL ISCHAEMIA Ref ID: 4154 Reference Wienbergen H, Kai GA, Schiele R et al. Actual clinical practice exercise ing

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Bucholz EM, Butala NM, Ma S, Normand S-LT, Krumholz HM. Life

More information

CLINICIAN INTERVIEW RECOGNIZING ACS AND STRATIFYING RISK IN PRIMARY CARE. An interview with A. Michael Lincoff, MD, and Eric R. Bates, MD, FACC, FAHA

CLINICIAN INTERVIEW RECOGNIZING ACS AND STRATIFYING RISK IN PRIMARY CARE. An interview with A. Michael Lincoff, MD, and Eric R. Bates, MD, FACC, FAHA RECOGNIZING ACS AND STRATIFYING RISK IN PRIMARY CARE An interview with A. Michael Lincoff, MD, and Eric R. Bates, MD, FACC, FAHA Dr Lincoff is an interventional cardiologist and the Vice Chairman for Research

More information

The Window for Fibrinolysis. Frans Van de Werf, MD, PhD Leuven, Belgium

The Window for Fibrinolysis. Frans Van de Werf, MD, PhD Leuven, Belgium The Window for Fibrinolysis Frans Van de Werf, MD, PhD Leuven, Belgium ESC STEMI Guidelines : December 2008 Reperfusion Therapy: Fibrinolytic Therapy Recommendations Class LOE In the absence of contraindications

More information

form of ACS, accounting for 25%-40% of MI presentations with in-hospital mortality of 5%-6% in the developed countries. 5

form of ACS, accounting for 25%-40% of MI presentations with in-hospital mortality of 5%-6% in the developed countries. 5 The Professional Medical Journal DOI: 10.29309/TPMJ/18.4763 ORIGINAL PROF-4763 ACUTE ST ELEVATION MYOCARDIAL INFARCTION; 70 % OR MORE ST SEGMENT RESOLUTION ON 90 MINUTES POST THROMBOLYSIS ELECTROCARDIOGRAM

More information

Case Study 50 YEAR OLD MALE WITH UNSTABLE ANGINA

Case Study 50 YEAR OLD MALE WITH UNSTABLE ANGINA Case Study 50 YEAR OLD MALE WITH UNSTABLE ANGINA Case History A 50-year-old man with type 1 diabetes mellitus and hypertension presents after experiencing 1 hour of midsternal chest pain that began after

More information

Clinical Policy Title: Cardiac rehabilitation

Clinical Policy Title: Cardiac rehabilitation Clinical Policy Title: Cardiac rehabilitation Clinical Policy Number: 04.02.02 Effective Date: September 1, 2013 Initial Review Date: February 19, 2013 Most Recent Review Date: February 6, 2018 Next Review

More information

VOLUME OF PRIMARY ANGIOPLASTY PROCEDURES AND SURVIVAL AFTER ACUTE MYOCARDIAL INFARCTION. Special Article

VOLUME OF PRIMARY ANGIOPLASTY PROCEDURES AND SURVIVAL AFTER ACUTE MYOCARDIAL INFARCTION. Special Article VOLUME OF PRIMARY ANGIOPLASTY PROCEDURES AND SURVIVAL AFTER ACUTE MYOCARDIAL INFARCTION Special Article THE VOLUME OF PRIMARY ANGIOPLASTY PROCEDURES AND SURVIVAL AFTER ACUTE MYOCARDIAL INFARCTION JOHN

More information

Older individuals are at greatest risk for developing and

Older individuals are at greatest risk for developing and Decade Long Trends (2001 2011) in Duration of Pre-Hospital Delay Among Elderly Patients Hospitalized for an Acute Myocardial Infarction Raghavendra P. Makam, MD, MPH; Nathaniel Erskine, BS; Jorge Yarzebski,

More information

Hon-Kan Yip, MD; Chiung-Jen Wu, MD; Morgan Fu, MD; Kuo-Ho Yeh, MD; Teng-Hung Yu, MD; Wei-Chin Hung, MD; and Mien-Cheng Chen, MD

Hon-Kan Yip, MD; Chiung-Jen Wu, MD; Morgan Fu, MD; Kuo-Ho Yeh, MD; Teng-Hung Yu, MD; Wei-Chin Hung, MD; and Mien-Cheng Chen, MD Clinical Features and Outcome of Patients With Direct Percutaneous Coronary Intervention for Acute Myocardial Infarction Resulting From Left Circumflex Artery Occlusion* Hon-Kan Yip, MD; Chiung-Jen Wu,

More information

Effect of intravenous atropine on treadmill stress test results in patients with poor exercise capacity or chronotropic incompetence ABSTRACT

Effect of intravenous atropine on treadmill stress test results in patients with poor exercise capacity or chronotropic incompetence ABSTRACT Effect of intravenous atropine on treadmill stress test results in patients with poor exercise capacity or chronotropic incompetence Samad Ghaffari, MD, Bahram Sohrabi, MD. ABSTRACT Objective: Exercise

More information

The role of thrombolytic drugs in the management of myocardial infarction

The role of thrombolytic drugs in the management of myocardial infarction European Heart Journal (1996) 17 (Supplement F), 9-15 The role of thrombolytic drugs in the management of myocardial infarction Comparative clinical trials W. D. Weaver MITI Coordinating Center, Seattle,

More information

Acute Coronary Syndrome (ACS) is the consequence of

Acute Coronary Syndrome (ACS) is the consequence of Clinical Practice Pharmaco-invasive Therapy for STEMI; The Most Suitable STEMI Reperfusion Therapy for Transferred Patients in Thailand Pradub Sukhum, MD. 1 1 Division of Cardiovascular Medicine, Bangkok

More information

Clinical Investigations

Clinical Investigations Clinical Investigations Application of Appropriate Use Criteria to Cardiac Stress Testing in the Hospital Setting: Limitations of the Criteria and Areas for Improved Practice Address for correspondence:

More information

Clinical Cardiology Prognostic Significance of the Initial Electrocardiogram in Patients With Acute Myocardial Infarction

Clinical Cardiology Prognostic Significance of the Initial Electrocardiogram in Patients With Acute Myocardial Infarction Clinical Cardiology Prognostic Significance of the Initial Electrocardiogram in Patients With Acute Myocardial Infarction William R. Hathaway, MD; Eric D. Peterson, MD, MPH; Galen S. Wagner, MD; Christopher

More information

ARIC Manuscript Proposal # PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority:

ARIC Manuscript Proposal # PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority: ARIC Manuscript Proposal # 1475 PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority: 1.a. Full Title: Hypertension, left ventricular hypertrophy, and risk of incident hospitalized

More information

Pre-hospital Delay in Treatment after Acute Myocardial Infarction

Pre-hospital Delay in Treatment after Acute Myocardial Infarction Journal of Korean Academy of Nursing (2001) Vol. 31, No. 7 Pre-hospital Delay in Treatment after Acute Myocardial Infarction Kyungeh An, RN, PhD. Significance of the study. Acute myocardial infarction

More information

Xi Li, Jing Li, Frederick A Masoudi, John A Spertus, Zhenqiu Lin, Harlan M Krumholz, Lixin Jiang for the China PEACE Collaborative Group

Xi Li, Jing Li, Frederick A Masoudi, John A Spertus, Zhenqiu Lin, Harlan M Krumholz, Lixin Jiang for the China PEACE Collaborative Group China PEACE risk estimation tool for inhospital death from acute myocardial infarction: an early risk classification tree for decisions about fibrinolytic therapy Xi Li, Jing Li, Frederick A Masoudi, John

More information

Primary PCI versus thrombolytic therapy: long-term follow-up according to infarct location

Primary PCI versus thrombolytic therapy: long-term follow-up according to infarct location Heart Online First, published on April 14, 2005 as 10.1136/hrt.2005.060152 1 Primary PCI versus thrombolytic therapy: long-term follow-up according to infarct location Short running head: Anterior infarction

More information

Responses to Symptoms of Acute Myocardial Infarction: Reasons for Delay and Bystanders Role

Responses to Symptoms of Acute Myocardial Infarction: Reasons for Delay and Bystanders Role Journal of Korean Academy of Nursing (2002) Vol. 32, No. 7 Responses to Symptoms of Acute Myocardial Infarction: Reasons for Delay and Bystanders Role Debra K. Moser, DNSc, RN, Kyungeh An, RN, PhD 2 Significance

More information

Annals of Internal Medicine. 1991;114:

Annals of Internal Medicine. 1991;114: Bypass Surgery for Chronic Stable Angina: Predictors of Survival Benefit and Strategy for Patient Selection Obi N. Nwasokwa, MD, PhD; Jerome H. Koss, MD; Gary H. Friedman, MD; Andrew M. Grunwald, MD; and

More information

OBJECTIVES BACKGROUND METHODS RESULTS CONCLUSIONS by the American College of Cardiology ISSN /00/$20.00

OBJECTIVES BACKGROUND METHODS RESULTS CONCLUSIONS by the American College of Cardiology ISSN /00/$20.00 Journal of the American College of Cardiology Vol. 36, No. 3, Suppl A 2000 by the American College of Cardiology ISSN 0735-1097/00/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)00888-3 Cardiogenic

More information

To Stent or Not To Stent: Focusing on the ISCHEMIA Trial to Redefine Treatment in Stable Ischemic Heart Disease

To Stent or Not To Stent: Focusing on the ISCHEMIA Trial to Redefine Treatment in Stable Ischemic Heart Disease : Focusing on the ISCHEMIA Trial to Redefine Treatment in Stable Ischemic Heart Disease Regina S. Druz, MD, FACC, FASNC* 2016, Regina S. Druz, MD, FACC, FASNC Journal Compilation 2016, AARM DOI 10.14200/jrm.2016.5.0107

More information

PAINLESS MYOCARDIAL INFARCTION; Its frequency in patients of acute coronary syndrome.

PAINLESS MYOCARDIAL INFARCTION; Its frequency in patients of acute coronary syndrome. ; Its frequency in patients of acute coronary syndrome. Dr. Ijaz-Ul-Haque Taseer, Dr. Shahzad Alam Khan, Dr. Muhammad Imran Nazir, Mr. Sohail Safdar ORIGINAL PROF-2264 ABSTRACT... Objective: To determine

More information

Abstract Objective To evaluate the benefits and risks of symptom limited exercise testing versus low level exercise testing soon after

Abstract Objective To evaluate the benefits and risks of symptom limited exercise testing versus low level exercise testing soon after Heart 1999;82:199 203 199 Prognostic value of symptom limited versus low level exercise stress test before discharge in patients with myocardial infarction treated with thrombolytics K Jensen-Urstad, B

More information

Original Research Factors Associated with Delay in Seeking Health Care for Hospitalized Patients with Acute Coronary Syndromes: The GREECS Study

Original Research Factors Associated with Delay in Seeking Health Care for Hospitalized Patients with Acute Coronary Syndromes: The GREECS Study Hellenic J Cardiol 47: 329-336, 2006 Original Research Factors Associated with Delay in Seeking Health Care for Hospitalized Patients with Acute Coronary Syndromes: The GREECS Study CHRISTOS PITSAVOS,

More information

Myocardial Infarction In Dr.Yahya Kiwan

Myocardial Infarction In Dr.Yahya Kiwan Myocardial Infarction In 2007 Dr.Yahya Kiwan New Definition Of Acute Myocardial Infarction The term of myocardial infarction should be used when there is evidence of myocardial necrosis in a clinical setting

More information

REFERRAL HOSPITAL. The Importance of Door In Door Out Time DIDO

REFERRAL HOSPITAL. The Importance of Door In Door Out Time DIDO REFERRAL HOSPITAL The Importance of Door In Door Out Time DIDO Jean Skonhovd,RN,BSN,MSAS Emergency Department Director Avera Heart Hospital of South Dakota Time to Treatment is critical for STEMI patients

More information

SHOULD A REGIONAL STEMI CENTRE ONLY OFFER PRIMARY PCI?

SHOULD A REGIONAL STEMI CENTRE ONLY OFFER PRIMARY PCI? SHOULD A REGIONAL STEMI CENTRE ONLY OFFER PRIMARY PCI? Kurt Huber, MD 3 Department of Internal Medicine, Cardiology and Intensive Care Medicine, Wilhelminenhospital, Vienna, Austria Disclosures DISCLOSURE

More information

Longer pre-hospital delay in acute myocardial infarction in women because of longer doctor decision time

Longer pre-hospital delay in acute myocardial infarction in women because of longer doctor decision time J Epidemiol Community Health 1999;53:459 464 459 Longer pre-hospital delay in acute myocardial infarction in women because of longer doctor decision time Jelte Bouma, Jan Broer, Jan Bleeker, Eric van Sonderen,

More information

Supplementary appendix

Supplementary appendix Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Cholesterol Treatment Trialists Collaboration.

More information

Effectiveness and cost-effectiveness of thrombolysis in submassive pulmonary embolism Perlroth D J, Sanders G D, Gould M K

Effectiveness and cost-effectiveness of thrombolysis in submassive pulmonary embolism Perlroth D J, Sanders G D, Gould M K Effectiveness and cost-effectiveness of thrombolysis in submassive pulmonary embolism Perlroth D J, Sanders G D, Gould M K Record Status This is a critical abstract of an economic evaluation that meets

More information

The Role of DHMC as an ST Elevation Myocardial Infarction Receiving Center in a Regional STEMI Care Network:

The Role of DHMC as an ST Elevation Myocardial Infarction Receiving Center in a Regional STEMI Care Network: The Role of DHMC as an ST Elevation Myocardial Infarction Receiving Center in a Regional STEMI Care Network: Nathaniel Niles, MD CREST Symposium November 7th, 28 STEMI = Acute Coronary Thrombosis STEMI

More information

Should All Patients Be Treated with Ace-inh /ARB after STEMI with Preserved LV Function?

Should All Patients Be Treated with Ace-inh /ARB after STEMI with Preserved LV Function? Should All Patients Be Treated with Ace-inh /ARB after STEMI with Preserved LV Function? Avi Shimony, MD, FESC Cardiology Division Soroka University Medical Center Ben-Gurion University, Beer-Sheva Disclosure

More information

Simon Horne 1 Clive Weston 2 * Tom Quinn 3 Anne Hicks 4 Lynne Walker 5 Ruoling Chen 6 John Birkhead 5

Simon Horne 1 Clive Weston 2 * Tom Quinn 3 Anne Hicks 4 Lynne Walker 5 Ruoling Chen 6 John Birkhead 5 The impact of pre-hospital thrombolytic treatment on re-infarction rates: analysis of the Myocardial Infarction National Audit Project (MINAP). Simon Horne 1 Clive Weston 2 * Tom Quinn 3 Anne Hicks 4 Lynne

More information

Safe discharge from the cardiac emergency room with a rapid rule-out myocardial infarction protocol using serial CK-MB mass

Safe discharge from the cardiac emergency room with a rapid rule-out myocardial infarction protocol using serial CK-MB mass Heart 2001;85:143 148 143 Department of Cardiology, Academic Medical Centre, Meibergdreef 9, 1105 AZ Amsterdam, Netherlands R Bholasingh R J de Winter J C Fischer R W Koster RJGPeters G T Sanders Correspondence

More information

Acute Coronary Syndrome in Phrae Hospital

Acute Coronary Syndrome in Phrae Hospital Acute Coronary Syndrome in Phrae Hospital Cardiovascular Unit, Department of Medicine, Phrae hospital, Phrae Thailand. Objective: To study the epidemiology, management and outcome of patients with acute

More information

Repeat ischaemic heart disease audit of primary care patients ( ): Comparisons by age, sex and ethnic group

Repeat ischaemic heart disease audit of primary care patients ( ): Comparisons by age, sex and ethnic group Repeat ischaemic heart disease audit of primary care patients (2002-2003): Comparisons by age, sex and ethnic group Baseline-repeat ischaemic heart disease audit of primary care patients: a comparison

More information

Journal of the American College of Cardiology Vol. 33, No. 3, by the American College of Cardiology ISSN /99/$20.

Journal of the American College of Cardiology Vol. 33, No. 3, by the American College of Cardiology ISSN /99/$20. Journal of the American College of Cardiology Vol. 33, No. 3, 1999 1999 by the American College of Cardiology ISSN 0735-1097/99/$20.00 Published by Elsevier Science Inc. PII S0735-1097(98)00644-5 Primary

More information